Halberd Co. (OTCMKTS:HALB – Get Free Report) saw a significant growth in short interest in October. As of October 15th, there was short interest totaling 157,854 shares. Based on an average daily trading volume, of 1,826,875 shares, the short-interest ratio is presently 0.1 days.
Halberd Stock Performance
Halberd stock traded up $0.00 during mid-day trading on Friday, reaching $0.00. 400 shares of the company were exchanged, compared to its average volume of 797,172. Halberd has a 12-month low of $0.00 and a 12-month high of $0.00.
About Halberd
Halberd Corporation is a biotechnology and medical-device company focused on developing technologies intended to remove harmful substances from the bloodstream and potentially improve the treatment of neurological and other serious medical conditions.
The company has described its research around extracorporeal blood-cleansing systems, which are designed to process blood outside the body and target substances such as inflammatory cytokines and other potentially damaging molecules. Halberd has indicated that its technology may have applications in conditions including traumatic brain injury, post-traumatic stress disorder and neurodegenerative diseases.
Halberd Corporation is headquartered in the United States and trades on the over-the-counter market under the symbol HALB.
Further Reading
- Five stocks we like better than Halberd
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Receive News & Ratings for Halberd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halberd and related companies with MarketBeat.com's FREE daily email newsletter.
